Friday , March 14 2025
Home / SNB & CHF (page 217)

SNB & CHF

SNB Study: Results of the Swiss Payment Methods Survey

In spring 2023, the Swiss National Bank conducted its second payment methods survey of companies in Switzerland. Around 1,750 companies, across all sizes, language regions and industries, participated in this survey on payment method topics. In-depth knowledge of these topics helps the SNB to fulfil its statutory tasks in relation to the supply and distribution of cash and to cashless payments. . The most important findings of the payment methods survey of...

Read More »

Rates, Risk and Debt: The Unavoidable Reckoning Ahead

Policy errors have consequences, and we’re only in the first inning of those consequences. Please note: Of Two Minds subscription rates are going up this Friday 3/1/24 from $5/month or $50/year to $7/month or $70/year, so subscribe by Thursday if you want to lock in current rates. Thank you for understanding the necessity of adjusting rates that have been unchanged since 2011. If we ask, “what’s changed?,” two under-appreciated dynamics pop out: risk and...

Read More »

EUR/CHF hits ten-week highs above 0.9550 as Franc continues to soften

EUR/CHF up over 3% from December’s lows. ECB President Lagarde looks ahead to growth rebound. Swiss Franc is broadly weaker across the majors market. EUR/CHF knocked into fresh multi-month highs on Monday as the pair steps into a ten-week peak above 0.9550. The Swiss Franc (CHF) has depreciated notably against the majority of its major currency peers in 2024, and is down 2.88% YTD against the Euro (EUR). European Central Bank (ECB) President Christine Lagarde hit...

Read More »

Who Hijacked Our Free Will?

Imagine someone giving a State of the World address that begins with a reminder that people possess free will and ought to be doing a better job of exercising it. This could possibly raise doubts about the speaker’s mental stability—at least until the talk went into the dark details of civilization’s condition. If the state of the world reflects the choices people make, and if those choices are autonomous, originating from within the minds of individuals, then the...

Read More »

Behind the scenes of our trip to discover the pharma industry in Slovenia | Part two 🇸🇮

When our reporter Jessica Davis Plüss found out that pharmaceutical giant Novartis had invested billions in Slovenia, helping turn the country into a global player in generic drug production, she wanted to find out more. So, she and our video journalist, Céline Stegmüller, went to Slovenia to investigate the pharma industry in the country. Watch this behind-the-scenes video to find out what they found interesting and surprising there. Tap here for more...

Read More »